Status: Recruiting
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
To explore the efficacy of Tislelizumab combined with chemotherapy in the treatment of locally unresectable esophageal squamous cell carcinoma (ESCC)
Participants needed: 93
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Fuzhou General HospitalUpdated: Feb 7, 2024Locations: 1
Eligibility criteria
Histologically confirmed localized ESCC that is suitable for cCRT, including: st... [+8]
A history of fistula caused by primary tumor invasion; [+10]